Validation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay with genital swabs and breast milk samples

被引:42
作者
Panteleeff, DD
Emery, S
Richardson, BA
Rousseau, C
Benki, S
Bodrug, S
Kreiss, JK
Overbaugh, J
机构
[1] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA
[2] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA
[3] Univ Washington, Div Microbiol, Seattle, WA 98195 USA
[4] Univ Washington, Div Biostat, Seattle, WA 98195 USA
[5] Univ Washington, Div Med, Seattle, WA 98195 USA
[6] Univ Washington, Div Epidemiol, Seattle, WA 98195 USA
[7] Gen Probe Inc, San Diego, CA USA
关键词
D O I
10.1128/JCM.40.11.3929-3937.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency type I (HIV-1) continues to spread at an alarming rate. The virus may be transmitted through blood, genital secretions, and breast milk, and higher levels of systemic virus in the index case, as measured by plasma RNA viral load, have been shown to correlate with increased risk of transmitting HIV-1 both vertically and sexually. Less is known about the correlation between transmission and HIV-1 levels in breast milk or genital secretions, in part because reliable quantitative assays to detect HIV-1 in these fluids are not available. Here we show that the Gen-Probe HIV-1 viral load assay can be used to accurately quantify viral load in expressed breast milk and in cervical and vaginal samples collected on swabs. Virus could be quantified from breast milk and swab samples spiked with known amounts of virus, including HIV-1 subtypes A, C, and D. As few as 10 copies of HIV-1 RNA could be detected above background threshold levels in greater than or equal to77% of assays performed with spiked breast milk supernatants and mock swabs. In genital swab samples from HIV-1-infected women, similar levels of HIV-1 RNA were consistently detected in duplicate swabs taken from the same woman on the same clinic visit, suggesting that the RNA values from a single swab sample can be used to measure genital viral load.
引用
收藏
页码:3929 / 3937
页数:9
相关论文
共 23 条
[1]   Comparison of two amplification technologies for detection and quantitation of human immunodeficiency virus type 1 RNA in the female genital tract [J].
Bremer, J ;
Nowicki, M ;
Beckner, S ;
Brambilla, D ;
Cronin, M ;
Herman, S ;
Kovacs, A ;
Reichelderfer, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (07) :2665-2669
[2]   Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection [J].
Chackerian, B ;
Long, EM ;
Luciw, PA ;
Overbaugh, J .
JOURNAL OF VIROLOGY, 1997, 71 (05) :3932-3939
[3]   Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission [J].
Chuachoowong, R ;
Shaffer, N ;
Siriwasin, W ;
Chaisilwattana, P ;
Young, NL ;
Mock, PA ;
Chearskul, S ;
Waranawat, N ;
Chaowanachan, T ;
Karon, J ;
Simonds, RJ ;
Mastro, TD .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (01) :99-106
[4]   Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya [J].
Emery, S ;
Bodrug, S ;
Richardson, BA ;
Giachetti, C ;
Bott, MA ;
Panteleeff, D ;
Jagodzinski, LL ;
Michael, NL ;
Nduati, R ;
Bwayo, J ;
Kreiss, JK ;
Overbaugh, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (07) :2688-2695
[5]   Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission [J].
Garcia, PM ;
Kalish, LA ;
Pitt, J ;
Minkoff, H ;
Quinn, TC ;
Burchett, SK ;
Kornegay, J ;
Jackson, B ;
Moye, J ;
Hanson, C ;
Zorrilla, C ;
Lew, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (06) :394-402
[6]   Distinct determinants of human immunodeficiency virus type 1 RNA and DNA loads in vaginal and cervical secretions [J].
Iversen, AKN ;
Larsen, AR ;
Jensen, T ;
Fugger, L ;
Balslev, U ;
Wahl, S ;
Gerstoft, J ;
Mullins, JI ;
Skinhoj, P .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (05) :1214-1220
[7]   Use of calibrated viral load standards for group m subtypes of human immunodeficiency virus type 1 to assess the performance of viral RNA quantitation tests [J].
Jagodzinski, LL ;
Wiggins, DL ;
McManis, JL ;
Emery, S ;
Overbaugh, J ;
Robb, M ;
Bodrug, S ;
Michael, NL .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (03) :1247-1249
[8]   Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: Association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections [J].
John, GC ;
Nduati, RW ;
Mbori-Ngacha, DA ;
Richardson, BA ;
Panteleeff, D ;
Mwatha, A ;
Overbaugh, J ;
Bwayo, J ;
Ndinya-Achola, JO ;
Kreiss, JK .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (02) :206-212
[9]   The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter [J].
Katzenstein, DA ;
Hammer, SM ;
Hughes, MD ;
Gundacker, H ;
Jackson, JB ;
Fiscus, S ;
Rasheed, S ;
Elbeik, T ;
Reichman, R ;
Japour, A ;
Merigan, TC ;
Hirsch, MS .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (15) :1091-1098
[10]   Timing of maternal-infant HIV transmission: Associations between intrapartum factors and early polymerase chain reaction results [J].
Kuhn, L ;
Abrams, EJ ;
Matheson, PB ;
Thomas, PA ;
Lambert, G ;
Bamji, M ;
Greenberg, B ;
Steketee, RW ;
Thea, DM ;
Beatrice, ST ;
Chiasson, MA ;
DeBernardo, E ;
Hutchison, S ;
McVeigh, K ;
Oleszko, W ;
Punsalang, A ;
Alford, T ;
Betre, A ;
Cappelli, M ;
Carrasquillio, N ;
Cruz, N ;
Floyd, J ;
FoyeSousou, V ;
Jessop, DJ ;
Macias, L ;
Ng, D ;
Nelson, K ;
Rios, J ;
Pliner, V ;
Rosenbluth, L ;
Hodge, R ;
Tadros, H ;
Weedon, J ;
Young, S ;
Zhang, ZR ;
Courtland, R ;
Daligadu, M ;
Hoover, W ;
Lopez, D ;
Pollack, H ;
Krasinski, K ;
Belmore, A ;
Champion, S ;
Freedland, C ;
Lovich, S ;
Prince, P ;
Rogers, A ;
Suarez, M ;
Chow, J ;
Kaul, A .
AIDS, 1997, 11 (04) :429-435